Comparative clinical studies with ebastine. Efficacy and tolerability

Drug Safety

Volumn 21, Issue SUPPL. 1, 1999, Pages 63-67

  Luria, Xavier ^a  

^a Almirall Prodesfarma ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EBASTINE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; HEADACHE; HUMAN; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PRURITUS; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SNEEZING; XEROSTOMIA;

EID: 0033429851     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199921001-00008     Document Type: Conference Paper

References (6)

1. Moragues J, Roberts DJ. Ebastine. Drugs Future 1990; 15: 674-9
2. Vincent J, Sumner DJ, Reid JL. Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects. Br J Clin Pharmacol 1988; 26: 503-8
3. Hopes H, Meuret GH, Ungethüm W, et al. Placebo controlled comparison of acute effects of ebastine and clemastine on performance and EEG. Eur J Clin Pharmacol 1992; 42: 55-9
4. Vincent J, Limiñana R, Meredith PA, et al. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol 1988; 26: 497-502
5. Luria X, Bakke OM. Ebastine (LAS W-090): overview of clinical trials. Drugs Today 1992; 28 Suppl. B: 69-79
6. Storms WW. Clinical studies of the efficacy and tolerability of ebastine 10 or 20mg once daily in the treatment of seasonal allergic rhinitis in the US. Drugs 1996; 52 Suppl. 1: 20-5